|
|
Volumn 25, Issue 5, 2011, Pages 604-605
|
|
The effects of liver impairment on opioids used to relieve pain in cancer patients
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALFENTANIL;
CODEINE;
DEXTROPROPOXYPHENE;
DIHYDROCODEINE;
FENTANYL;
HYDROMORPHONE;
METHADONE;
MORPHINE;
OPIATE;
OXYCODONE;
OXYMORPHONE;
PETHIDINE;
TRAMADOL;
ANALGESIA;
ANALGESIC ACTIVITY;
AREA UNDER THE CURVE;
BILE DUCT CARCINOMA;
CANCER INFILTRATION;
CANCER PAIN;
CANCER PATIENT;
DRUG ABSORPTION;
DRUG ACCUMULATION;
DRUG BIOAVAILABILITY;
DRUG CLEARANCE;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG GLUCURONIDATION;
DRUG HALF LIFE;
DRUG METABOLISM;
HUMAN;
LETTER;
LIVER CANCER;
LIVER CELL CARCINOMA;
LIVER DYSFUNCTION;
LIVER FUNCTION;
LIVER METASTASIS;
MAXIMUM PLASMA CONCENTRATION;
PORTOCAVAL SHUNT;
ANALGESICS, OPIOID;
HEPATIC INSUFFICIENCY;
HUMANS;
NEOPLASMS;
PAIN;
|
|
EID: 79959885198
PISSN: 02692163
EISSN: 1477030X
Source Type: Journal
DOI: 10.1177/0269216311401642 Document Type: Letter |
|
Times cited : (12)
|
|
References (7)
|
